Therapeutic Equivalence Studies for locally applied/acting products (Bioequivalence studies with Clinical End-point) Ophthalmic (leading CRO in Europe), Inhalers, Dermatological, Anesthetics and NSAIDs, Intra-Vaginal, Otic and Nasal.